Drugs / Dun Ye Guan Xin Ning
last change Dec 2018 re-read 3 minutes ago

Dun Ye Guan Xin Ning

Developed for
coronary artery disorder
Investigated by
Jiangsu Wanbang Pharmaceutical Marketing Co.,Ltd. · Peking University First Hospital

Trials 1

20172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT03198091 Mar 2017 → Jun 2018 coronary artery disorder Peking University First Hospital Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Dun Ye Guan Xin Ning ClinicalTrials.gov intervention name — accepted as the source's own label NCT03198091 ↗
Route Oral “320 mg orally every time” NCT03198091 ↗